Event review – Overview

Successful 4th International CytoSorb Users Meeting 2017

The day before the start of the 37th ISICEM, the 4th International Users Meeting brought together 120 CytoSorb users and other interested parties from a total of 22 countries. The international faculty shared an update on the latest scientific findings, recent study results and case series in different patient groups, followed by a podium discussion. Between the lectures the participants could benefit from the possibility to exchange their experiences made with the CytoSorb therapy. To date, CytoSorb therapy has been used in more than 20,000 human treatments in more than 450 hospitals around the world. 


The following documtens are available for download within the Cytosorbents Community Area.

>> Link to Cytosorbents Community Area

International registry on the use of the CytoSorb®-Adsorber in ICU patients (NCT02312024) – study protocol and preliminary results

Brunkhorst M. F.

CytoSorb in early septic shock – The ACESS trial

Molnár Z.

Clinical experience with CytoSorb in sepsis: A 30 patients case series

Mitzner S.

Clinical experiences in endocarditis - An intraoperative case series

Träger K.

Continuous Hemodiafiltration with a Cytokine-Adsorber During Sepsis

Houschyar K.

New therapeutic options in Rhabdomyolysis

Martinez B.

CytoSorb in kidney and liver transplantations – Experiences from Hungary

Fazakas J

Safety aspects and effects of CytoSorb on the immune System

A. Nierhaus

Media Gallery